It has been reported that Lysine-305 is needed for the nuclear import of the p53 protein (Liang et al., 1998) . In the present study, further mutagenesis analyses were carried out between Lys-305 and the major nuclear localization signal (NLS I) of p53. It was found that a single mutation of Arg-306 resulted in the defect of p53 nuclear import. This eect is the same as that of Lys-305 mutation. Other mutations between Arg-306 and NLS I have no eect on the nuclear import of p53. However, deletions of more than two amino acids between this region abolished the transport of p53 into the nucleus. These results indicate that a basic domain other than the well de®ned NLS is required for the nuclear import of p53. A spacer between this basic domain and NLS I is necessary for the entrance of p53 into the cell nucleus.
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The p53 tumor suppressor is a nuclear phosphoprotein involved in the control of cell proliferation. Mutations of p53, including point mutation, deletion or allelic loss, and rearrangement, are frequently detected in diverse types of human cancers (Hollstein et al., 1991) . Mutation, however, is not the only way in which p53 functions are inhibited. Certain human cancers (breast cancers, colon cancers, and neuroblastoma) may do so by sequestering the wild-type p53 in the cytoplasm (Moll et al., 1992 (Moll et al., , 1995 Bosari et al., 1995) .
It has been shown that cellular tracking of p53 is cell cycle-dependent in untransformed ®broblast cells (Shaulsky et al., 1990a) and murine erythroleukemia cells (Ryan et al., 1994) . In these cells, p53 enters the nucleus during G1-S transition. Other than this part of the cell cycle, p53 is accumulated in the cytoplasm. Although the mechanism that regulates p53 nuclear exclusion is still not clear, the process of selective transportation of nuclear protein to the nucleus has been well de®ned. The nuclear localization signal (NLS), a short sequence containing a basic amino acid core surrounded by a-helix-breaking amino acids, was ®rst identi®ed in SV40 large T antigen (Kalderon et al., 1984) . A similar NLS (PQPKKKP; NLS I) was later identi®ed in p53 together with two additional but less conserved and ecient NLSs (NLS II and NLS III) in the C-terminus of the protein (Shaulsky et al., 1990b) . The presence of the NLS is necessary for the binding of importin a and initiates the process for p53 nuclear import (GoÈ rlich and Mattaj, 1996; Koepp and Silver, 1996) .
Although a NLS alone is sucient to direct cytoplasmic proteins to the cell nucleus (Dang and Lee, 1989) , it seems that the function of NLS is dependent on the protein context within which it is located (Roberts et al., 1987) . We have hypothesized that some other cis-domains except NLS I could be involved in p53 compartmentalization within the cell. Previous mutation analysis revealed that amino acid Lys-305 is required for nuclear import of p53 and this lysine, together with the NLS I and a cytoplasmic sequestration domain (CSD, from residues 326 to 355) located in the C-terminus of p53 regulates the cellular localization of p53 (Liang et al., 1998) . We have noticed that Lys-305 is a conserved residue throughout a variety of species from human to Xenopus (Soussi et al., 1990; Soussi and May, 1996) . Similarly, it was found that Arg-306, a residue adjacent to Lys-305, is also conserved. This evolutionary conservation lets us speculate that Arg-306 may also be a functionally signi®cant amino acid of p53.
To address this hypothesis, Arg-306 was mutated to Ala and Lys by the PCR SOEing technique (Horton et al., 1990) . The mutated p53 was ligated to the Cterminus of the green¯uorescent protein (GFP) in pK7-GFP vector (kindly provided by IG Macara, University of Virginia) (Carey et al., 1996) . The plasmid was transiently transfected into MCF-7 breast cancer cells grown on coverslips using LipofectAMINE (GIBCO-BRL). Forty-eight hours after transfection, cells were washed and ®xed by 4% paraformaldehyde and examined by¯uorescence microscopy. According to the relative intensity of green¯uorescence in the cytoplasm and the nucleus of each individual cell, subcellular distributions of the p53/GFP fusion were divided into three groups as nuclear (N), cytoplasmic (C), and both nuclear and cytoplasmic (N+C) localizations. The percentage of each localization was determined from a total of 400 to 500¯uorescent cells observed in several ®elds of a slide.
The data show that while wild-type p53 is located predominantly in the nucleus or both the nucleus and the cytoplasm (98% combined), mutation of Arg-306 leads to the cytoplasmic localization of the p53/GFP fusion protein (Figures 1 and 2a,b) . This cytoplasmic sequestration eect of Arg-306 mutation is similar to that of Lys-305 mutation (Liang et al., 1998) . No synergetic eect is found when Lys-305 and Arg-306 were both replaced by Ala (Figure 1 ). These results indicate that the nuclear import of p53 requires both Lys-305 and Arg-306. We reported earlier that cytoplasmic sequestration of Lys-305 mutant is partially dependent upon the presence of a cytoplasmic sequestration domain (CSD) spanning amino acids 326 to 355 (Liang et al., 1998) . Here we also examined the relationship between the cytoplasmic localization of the Arg-306 mutants and the CSD. The results showed that Arg-306 mutant is still located in the cytoplasm when amino acid residues after 355 were deleted (Figure 3a) . However, when residues after 350 were deleted, Arg-306 mutant lost the ability to accumulate only in the cytoplasm and turn out to distribute to both the cytoplasm and the nucleus (Figure 3b) . A variety of internal deletion between residues 326 to 355 also resulted in the nuclear localization of the Arg-306 mutated p53 (data not shown). These results indicate that Lys-305 and Arg-306 mutants behave in the same way with respect to the interaction with CSD.
To rule out an interaction of the mutated p53 with endogenous wild-type p53 in MCF-7 cells, we examined the localization of the various p53 mutants in SAOS-2 cells which lack p53. The Arg-306 mutation also aected nuclear tracking of p53 when we examined the localization of transiently expressed p53R306A/GFP protein in SAOS-2 cells. In contrast with wild-type p53 which is located primarily in the nucleus (Figure 4a) , the Arg-306 mutated p53 is localized in both the nuclear and the cytoplasm of all transfected SAOS-2 cells with 50% of them having stronger cytoplasmic¯uorescence (Figure 4b ). Localizations of the Arg-306 mutated p53 with truncated CSD proteins in SAOS-2 cells (Figure 4c ) are similar to those in the MCF-7 cells (Figure 3b ). Taken together, although the degree of cytoplasmic sequestration varies slightly among dierent cell lines, it is concluded that a basic domain containing Lys-305 and Arg-306 is a functional domain in directing the nuclear localization of p53. Additionally, a domain from amino acid residues 326 to 355 also plays a role in the cytoplasmic sequestration of Lys-305 or Arg-306 mutated p53.
Although it is possible that the GFP could interfere with normal tracking of p53, our observations suggest that this is not the case. By immunostaining of the transiently transfected SAOS-2 cells, it was found that the localizations of non-GFP fusion of wild-type and mutated p53 proteins are similar to those of GFP fusions, although the percentage of each accumulated pattern is slightly dierent. The wildtype p53 is located only in the nucleus of 90% of the transfected SAOS-2 cells, whereas the Lys-305 or Arg-306 mutated protein is located in both the nucleus and the cytoplasm of virtually 100% of the transfected SAOS-2 cells with 10% of them having stronger cytoplasmic staining (data not shown). Furthermore, it has been shown that mutation of Lys-305, which is not located in the p53 transcriptional activation domain, signi®cantly lost the ability to induce the expression of p21 in SAOS-2 cells (Liang et al., 1998) . These data are in accordance with the cytoplasmic sequestration eect of Lys-305 mutation observed from GFP fusion protein.
Considering the p53 NLS I (see Figure 1 ) plays a central role in the nuclear import of p53, it is reasonable to speculate that the basic domain we identi®ed may aect the function of NLS I, the CSD, or both. If so, then the relative position of Lys-305 and Arg-306 to NLS I and/or the CSD is essential for the nuclear localization of p53. To test this, several amino acids between residues 307 and 315 were mutated. The subcellular localization of these mutants resembles that of wild-type p53 (Figure 1 and Figure  5a ). In contrast, deletion of more than two amino acids from residues 307 to 315 resulted in the (Horton et al., 1990) as described before (Liang et al., 1998) . All constructs were sequenced to ensure no mutation occurred except the designed mutation Figure 2 Eects of Arg-306 mutation on the subcellular localization of p53. The GFP fusion of wild-type p53 (a), and Arg-306 mutant, p53R306A (b) were transiently transfected into MCF-7 cells grown on coverslips in six-well plates (35 mm diameter) using LipofectAMINE according to manufacturer's instructions. The transfected cells were examined at 48 h after transfection by¯uorescence microscopy using a FITC ®lter to detect expression of GFP fusion proteins Figure 3 Interaction of Arg-306 with a cytoplasmic sequestration domain in the C-terminus of the p53 protein. The GFP fusion of p53R306AD356 (a), and p53R306AD351 (b) were transiently transfected into MCF-7 cells and examined as described in Figure 2 cytoplasmic sequestration of the mutant (Figures 1 and  5b,c) . These results indicate that a spacer between Lys-305 or Arg-306 and NLS I and/or CSD is necessary for the nuclear import of p53.
The nuclear localization signals of p53 and SV40 large T antigen have long been classi®ed into the same group as a single and short stretch rich in basic amino acids. The other class of nuclear localization signal, which is represented by that of nucleoplasmin, is bipartite, consisting of two separated clusters of basic amino acid residues. The nuclear localization signal of nucleoplasmin, for example, contains a Lys-Arg and a Lys-Lys-Lys-Lys domains separated by ten amino acids which can tolerate point mutations but not deletions. Both basic domains are required for nuclear import of nucleoplasmin (Robbins et al., 1991) . In some respects, our novel ®nding of a Lys-Arg domain involved in the nuclear import of p53 seems to place the NLS I of p53 into the bipartite group. However, there are several facts that indicate NLS I of p53 may not ®t well with the bipartite NLS. Unlike the Lys-Lys-Lys-Lys domain of nucleoplasmin, NLS I of p53 alone is sucient to direct the nuclear import of cytoplasmic proteins (Dang and Lee, 1989) . Next, in nucleoplasmin, the lysine residue of the Lys-Arg pair can be replaced by arginine without aecting the nuclear import (Robbins et al., 1991) . In contrast, our data show that mutation of Lys-305 to Arg results in cytoplasmic sequestration of p53 (Figure 1) . Finally, deletion of the CSD results in nuclear import of the Lys-305 or Arg-306 mutated p53. For these reasons, we still consider that NLS I of p53 is an independent domain for nuclear targeting. The basic domain, Lys-Arg, which sits nine amino acids away from NLS I may play a role to structurally open the NLS I for binding to the nuclear protein receptor, importin a, by interacting with the CSD. The CSD domain of p53 overlaps with the tetramerization domain. At this time, it is unclear whether these functions are related. It is possible that tetramerization aects the nuclear import or export of p53. Alternatively, this domain may function independently to regulate subcellular tracking and oligomerization of the p53 protein.
The nuclear import of p53 cannot be rescued when Lys-305 and Arg-306 are replaced by basic residues Arg and Lys, respectively (Figure 1 ). This suggests that Lys-Arg is a very speci®c sequence possibly involved in some kind of modi®cation. Without this speci®c modi®cation or mutation of Lys-305 and Arg-306, these amino acids could interact with the CSD to cause p53 to remain in the cytoplasm. For example, the CSD might structurally mask the NLS I when Lys-306 or Arg-306 are mutated. It is also possible that a protein could bind to CSD without the modi®cation or presence of Lys-305 and Arg-306 residues and block the interaction of NLS I with importin a. On the other hand, the Lys-Arg domain and CSD may also be involved in the nuclear export of p53. Although the mechanism of regulating p53 nuclear export is still unclear, studies have shown that export of proteins from the nucleus is mediated by the nuclear export factor such as CRM1 or Exportin1 (Fornerod et al., 1997; Stade et al., 1997; Ullmann et al., 1997) . Accordingly, the cytoplasmic sequestration of Lys-305 and Arg-306 mutated p53 could result from the enhancement of the nuclear export, for example, by increasing the interaction with the nuclear export factor. The Lys-Arg domain and CSD could thus be associated with both the nuclear import and export of the p53. Studies are underway to test these hypotheses. Figure 4 Eects of Arg-306 mutation on p53 subcellular localization in SAOS-2 cells. The GFP fusion of wild-type p53 (a), Arg-306 mutant, p53R306A (b), and C-terminal truncated Arg-306 mutant, p53R306AD341 (c) were transiently transfected into SAOS-2 cells in the same way as described for MCF-7 cells Figure 5 A spacer between the Lys-Arg domain and the nuclear localization domain is required for the nuclear import of p53. Fluorescent images (a) shows the nuclear localization of the GFP fusion of p53P309-S314A in which resides 309 ± 314 were mutated to alanine. While p53D307 ± 308 is still located in the nucleus (b), p53D307 ± 310 is accumulated in the cytoplasm (c)
